You can find the annual or quarterly income statement of Liminatus Pharma Ord Shs Class A here for insights into the performance and operational efficiency of Liminatus Pharma Ord Shs Class A.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Operating expenses

-31.24%701.17K

-17.60%522.79K

50.77%1.02M

70.90%642.08K

17.07%721.75K

-51.83%634.43K

310.49%676.32K

28.67%375.70K

5.45%616.49K

-8.88%1.32M

-208.72%-321.30K

-26.12%291.99K

46.88%584.63K

--1.45M

--295.52K

--395.23K

--398.02K

R&D expenses

--0.00

----

Depreciation, depletion, and amortization

--542.00

--0.00

----

Other operating expenses

----

-17.60%522.79K

50.77%1.02M

70.90%642.08K

17.07%721.75K

-51.83%634.43K

310.49%676.32K

28.67%375.70K

5.45%616.49K

-8.88%1.32M

-208.72%-321.30K

-26.12%291.99K

46.88%584.63K

--1.45M

--295.52K

--395.23K

--398.02K

Operating profit

31.24%-701.17K

17.60%-522.79K

-50.77%-1.02M

-70.90%-642.08K

-17.07%-721.75K

51.83%-634.43K

-310.49%-676.32K

-28.67%-375.70K

-5.45%-616.49K

8.88%-1.32M

208.72%321.30K

26.12%-291.99K

-46.88%-584.63K

---1.45M

---295.52K

---395.23K

---398.02K

Net non-operating interest income (expenses)

Non-operating interest income

-100.00%0.00

-48.77%24.13K

-92.18%32.99K

--33.36K

-44.22%47.24K

-98.36%47.09K

1070.61%421.85K

-100.00%0.00

1144.26%84.70K

41753.68%2.87M

535.24%36.04K

3637.89%161.10K

--6.81K

--6.86K

--5.67K

--4.31K

----

Non-operating interest expense

--19.05K

22.82%136.76K

--0.00

--1.34K

--111.35K

----

Special income (expenses)

82.50%636.87K

-201.83%-229.84K

861.58%348.97K

-86.85%78.64K

-61.02%-176.53K

119.32%225.70K

-101.82%-45.82K

-84.44%598.18K

-102.50%-109.64K

-199.77%-1.17M

-64.29%2.52M

1572.15%3.84M

380.67%4.39M

--1.17M

--7.05M

--229.86K

---1.57M

Other non-operating income (expenses)

---1.74M

----

Income before tax

-185.91%-1.82M

-82.93%-865.26K

-112.37%-637.74K

-338.25%-530.07K

-32.89%-852.38K

-222.72%-473.00K

-110.44%-300.29K

-94.01%222.48K

-116.81%-641.43K

243.91%385.44K

-57.48%2.88M

2405.10%3.71M

294.34%3.82M

---267.84K

--6.76M

---161.06K

---1.96M

Income tax

----

-77.57%3.05K

-78.12%5.16K

145.52%4.78K

-19.75%5.85K

-96.57%13.60K

-83.58%23.60K

---10.50K

--7.29K

--396.07K

--143.75K

----

Income after tax

-183.61%-1.82M

-78.45%-868.31K

-98.49%-642.90K

-329.57%-534.85K

-32.30%-858.23K

-4474.55%-486.60K

-111.86%-323.89K

-93.72%232.98K

-117.00%-648.72K

96.03%-10.64K

-59.61%2.73M

2405.10%3.71M

294.34%3.82M

---267.84K

--6.76M

---161.06K

---1.96M

Net income from continuous operations

-183.61%-1.82M

-78.45%-868.31K

-98.49%-642.90K

-329.57%-534.85K

-32.30%-858.23K

-4474.55%-486.60K

-111.86%-323.89K

-93.72%232.98K

-117.00%-648.72K

96.03%-10.64K

-59.61%2.73M

2405.10%3.71M

294.34%3.82M

---267.84K

--6.76M

---161.06K

---1.96M

Net income attributable to controlling interests

-183.61%-1.82M

-78.45%-868.31K

-98.49%-642.90K

-329.57%-534.85K

-32.30%-858.23K

-4474.55%-486.60K

-111.86%-323.89K

-93.72%232.98K

-117.00%-648.72K

96.03%-10.64K

-59.61%2.73M

2405.10%3.71M

294.34%3.82M

---267.84K

--6.76M

---161.06K

---1.96M

Net income attributable to common shareholders

-183.61%-1.82M

-78.45%-868.31K

-98.49%-642.90K

-329.57%-534.85K

-32.30%-858.23K

-4474.55%-486.60K

-111.86%-323.89K

-93.72%232.98K

-117.00%-648.72K

96.03%-10.64K

-59.61%2.73M

2405.10%3.71M

294.34%3.82M

---267.84K

--6.76M

---161.06K

---1.96M

Basic earnings per share

21.79%-0.07

-82.65%-0.12

-124.89%-0.09

-365.50%-0.07

-51.17%-0.12

-21406.45%-0.07

-150.33%-0.04

-73.95%0.03

-170.56%-0.08

96.01%0.00

-59.61%0.08

2404.28%0.11

294.34%0.11

---0.01

--0.20

--0.00

---0.06

Diluted earnings per share

21.79%-0.07

-82.65%-0.12

-124.89%-0.09

-365.50%-0.07

-51.17%-0.12

-21406.45%-0.07

-150.33%-0.04

-73.95%0.03

-170.56%-0.08

96.01%0.00

-59.61%0.08

2404.28%0.11

294.34%0.11

---0.01

--0.20

--0.00

---0.06

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

